About Methylomics

Methylomics is a company that applies state of the art molecular diagnostic technologies to develop novel assays for monitoring cancer progression and therapy response. We study the epigenome by genome wide DNA methylation profiles in healthy and diseased tissue to detect differences that can be used as methylation markers. We are experienced in reseach and product development of cancers of the colorectal region, skin and uro-genital zone including cervical, ovarian, vulva and endometrial cancers. Methylomics is a young company founded in 2018, located in Rijswijk the Netherlands.

error: Content is protected !!